# Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients

> **NCT02205164** · PHASE2 · UNKNOWN · sponsor: **Associazione Salentina Angela Serra** · enrollment: 134 (estimated)

## Conditions studied

- Chemotherapy Induced Nausea and Vomiting

## Interventions

- **DRUG:** Palonosetron + Aprepitant
- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT02205164
- **Lead sponsor:** Associazione Salentina Angela Serra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-10
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02205164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02205164, "Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02205164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*